default search action
"Pharmacokinetic Tumor Heterogeneity as a Prognostic Biomarker for ..."
Majid Mahrooghy et al. (2015)
- Majid Mahrooghy, Ahmed Bilal Ashraf, Dania Daye, Elizabeth S. McDonald, Mark Rosen, Carolyn Mies, Michael D. Feldman, Despina Kontos:
Pharmacokinetic Tumor Heterogeneity as a Prognostic Biomarker for Classifying Breast Cancer Recurrence Risk. IEEE Trans. Biomed. Eng. 62(6): 1585-1594 (2015)
manage site settings
To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.